𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells

✍ Scribed by M. Odenlund; B. Holmqvist; B. Baldetorp; P. Hellstrand; Bengt-Olof Nilsson


Publisher
Springer
Year
2008
Tongue
English
Weight
389 KB
Volume
36
Category
Article
ISSN
0939-4451

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Hesperetin, a bioflavonoid, inhibits rat
✍ Yong-Ri Jin; Xiang-Hua Han; Yong-He Zhang; Jung-Jin Lee; Yong Lim; Tack-Joong Ki 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

## Abstract Diet can be one of the most important factors that influence risks for cardiovascular diseases. Hesperetin, a flavonoid present in grapefruits and oranges, is one candidate that may benefit the cardiovascular system. In this study, we have investigated the effect of hesperetin on the pl

Adenylyl cyclase-cAMP system inhibits th
✍ Kouseki Hirade; Kumiko Tanabe; Masayuki Niwa; Akira Ishisaki; Keiichi Nakajima; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

## Abstract We previously reported that thrombin stimulates the induction of heat shock protein (HSP) 27 via p38 mitogen‐activated protein (MAP) kinase activation in aortic smooth muscle A10 cells. In the present study, we investigated the effect of the adenylyl cyclase‐cAMP system on the thrombin‐

PDTC, metal chelating compound, induces
✍ Sung-Kwon Moon; Sun-Young Jung; Yung-Hyun Choi; Young-Choon Lee; Cam Patterson; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

Pyrrolidine dithiocarbamate (PDTC), a metal chelating compound, is known to induce cell death in vascular smooth muscle cells (VSMC). However, the molecular mechanism for PDTC-induced VSMC death is not well understood. Addition of PDTC reduced cell growth and DNA synthesis on VSMC in low density con

Statins inhibit in vitro calcification o
✍ Akane Kizu; Atsushi Shioi; Shuichi Jono; Hidenori Koyama; Yasuhisa Okuno; Yoshik 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

## Abstract Although lipid‐lowering therapy with 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) decreases the progression of coronary artery and aortic valve calcification, the mechanism of action of these drugs to inhibit the calcification process remains unclear. In this stu